Drug intelligence / Profile preview

thallous chloride tl-201

Development stage
Approved
Lead developer
Lantheus
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Thallous chloride Tl-201 is a radiopharmaceutical used primarily as a diagnostic agent in nuclear medicine. It consists of the radioactive isotope thallium-201 in the form of its chloride salt. The drug is administered intravenously and is most commonly used for myocardial perfusion imaging to diagnose coronary artery disease by identifying areas of reduced blood flow to the heart muscle using planar scintigraphy or single-photon emission computed tomography (SPECT). It can detect both non-reversible defects (myocardial infarction) and reversible defects (myocardial ischemia), especially when combined with exercise or pharmacologic stress testing[2][8]. Thallous chloride Tl-201 is also indicated for localizing sites of parathyroid hyperactivity in patients with elevated serum calcium and parathyroid hormone levels[1][2]. Mechanistically, after intravenous administration, thallium ions mimic potassium and are actively transported into myocardial cells via the Na+/K+ ATPase pump; their distribution reflects regional blood flow and cell viability[6]. Thallium-201 decays by electron capture with a physical half-life of about 73 hours, emitting photons suitable for imaging[3][6].

Brand names
Thallous Chloride Tl 201 Injection
Other names
thallium(201Tl) chlorideThallium Chloride Tl 201 Injection
02

Targets

ATP1A (Sodium/potassium-transporting ATPase)

Beyond the preview

Go deeper on thallous chloride tl-201.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thallous chloride tl-201.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call